Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
 
You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
 
    2
    ...
ATC Name B/G Ingredients Dosage Form Price
V03AE03 FOSRENOL B Lanthanum Carbonate - 500mg 500mg Tablet, chewable 7,825,491 L.L
V03AE03 FOSRENOL B Lanthanum Carbonate - 750mg 750mg Tablet, chewable 10,073,351 L.L
V03AE03 FOSRENOL B Lanthanum Carbonate - 750mg 750mg Tablet, chewable 10,073,351 L.L
V03AE02 RENVELA B Sevelamer carbonate - 2.4g 2.4g Powder for suspension 18,651,166 L.L
V03AE02 RENVELA B Sevelamer - 800mg 800mg Tablet, film coated 8,386,876 L.L
V03AE02 FOSEAL-800 G Sevelamer HCl - 800mg 800mg Tablet, film coated 470,345 L.L
V03AE02 FOSEAL-800 G Sevelamer HCl - 800mg 800mg Tablet, film coated 7,977,094 L.L
V03AE02 SEVELAMER CARBONATE ARROW G Sevelamer carbonate - 800mg 800mg Tablet, film coated 8,689,985 L.L
V03AE02 RENVELA B Sevelamer carbonate - 2.4g 2.4g Powder for suspension 7,783,475 L.L
V03AE02 SEVELAMER CARBONATE ARROW G Sevelamer - 2.4g 2.4g Powder for suspension 13,501,999 L.L
V03AE01 CALCIUM RESONIUM B Calcium Polystyrene Sulphonate - 15g 15g Powder 2,154,180 L.L
V03AE01 RESICAL G Calcium Polystyrene Sulphonate - 93.5% w/w 93.5% Powder 1,173,175 L.L
V03AE01 RESONIUM A B Sodium Polystyrene Sulphonate - 99.934%w/w 99.934%w/w Powder 2,390,696 L.L
V03AE01 RESINSODIO G Sodium polystyrene sulphonate - 99.75g/100g 99.75g/100g Powder for suspension 1,535,160 L.L
V03AC03 DIFIRAX G Deferasirox - 250mg 250mg Tablet, dispersible 9,042,381 L.L
V03AC03 DIFIRAX G Deferasirox - 250mg 250mg Tablet, dispersible 9,687,328 L.L
V03AC03 DEFIROX G Deferasirox - 500mg 500mg Tablet, dispersible 38,502,953 L.L
V03AC03 DIFIRAX G Deferasirox - 500mg 500mg Tablet, dispersible 582,009 L.L
V03AC03 ENFEROX G Deferasirox - 500mg 500mg Tablet, dispersible 15,741,317 L.L
V03AC03 JADENU B Deferasirox - 180mg 180mg Tablet, film coated 14,339,031 L.L
V03AC03 DIFIRAX G Deferasirox - 250mg 250mg Tablet, dispersible 21,667,822 L.L
V03AC03 JADENU B Deferasirox - 360mg 360mg Tablet, film coated 1,090,731 L.L
V03AC03 DIFIRAX G Deferasirox - 250mg 250mg Tablet, dispersible 23,213,276 L.L
V03AC03 JADENU B Deferasirox - 180mg 180mg Tablet, film coated 35,669,509 L.L
V03AC03 JADENU B Deferasirox - 360mg 360mg Tablet, film coated 66,498,152 L.L
V03AB37 PRAXBIND BioTech Idarucizumab - 50mg/ml 50mg/ml Injectable solution 4,585,216 L.L
V03AB35 BRIDION B Sugammadex - 100mg/ml 100mg/ml Injectable solution 65,228,611 L.L
V03AB14 PROSULF 1% B Protamine sulfate - 50mg/5ml 1% Injectable solution 8,216,459 L.L
V01AA STALORAL B Allergen extracts - 2 x 100IR ou IC/ml Solution 8,449,319 L.L
V01AA STALORAL B Allergen extracts - 300 IR ou IC/ml Solution 6,598,267 L.L
    2
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2024